Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose by Johnston, NR et al.
Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose.
Johnston, NR; Mitchell, RK; Haythorne, E; Pessoa, MP; Semplici, F; Ferrer, J; Piemonti, L;
Marchetti, P; Bugliani, M; Bosco, D; Berishvili, E; Duncanson, P; Watkinson, M; Broichhagen,
J; Trauner, D; Rutter, GA; Hodson, DJ
 
 
 
 
 
© 2016 The Author(s). Published by Elsevier Inc
http://dx.doi.org/10.1016/j.cmet.2016.06.020
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15117
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
1 
 
Title: Beta cell hubs dictate pancreatic islet responses to glucose 1 
 2 
Authors: Natalie R. Johnston1, Ryan K. Mitchell1, Elizabeth Haythorne1, Maria Paiva Pessoa1, 3 
Francesca Semplici1, Jorge Ferrer2, Lorenzo Piemonti3, Piero Marchetti4, Marco Bugliani4, 4 
Domenico Bosco5, Ekaterine Berishvili5, Philip Duncanson6, Michael Watkinson6, Johannes 5 
Broichhagen7, Dirk Trauner7, Guy A. Rutter1* and David J. Hodson1,8,9* 6 
 7 
Affiliations: 1Section of Cell Biology and Functional Genomics, Division of Diabetes, 8 
Endocrinology and Metabolism, Department of Medicine, Imperial College London, London 9 
W12 0NN, UK. 2Beta Cell Genome Regulation Lab, Department of Medicine, Imperial College 10 
London, London W12 0NN, UK. 3Diabetes Research Institute (HSR-DRI), San Raffaele 11 
Scientific Institute, Via Olgettina 60, 20132 Milan, Italy. 4Department of Clinical and 12 
Experimental Medicine, Islet Cell Laboratory, University of Pisa, Pisa, Italy. 5Cell Isolation and 13 
Transplantation Center, Department of Surgery, Geneva University Hospitals and University of 14 
Geneva, Geneva, Switzerland. 6School of Biological and Chemical Sciences, Queen Mary 15 
University of London, Mile End Road, London, E1 4NS, UK. 7Department of Chemistry, 16 
Ludwig-Maximilians-Universität München, and Munich Center for Integrated Protein Science, 17 
Butenandtstrasse 5-13, 81377 München, Germany. 8Institute of Metabolism and Systems 18 
Research (IMSR), University of Birmingham, Edgbaston, B15 2TT, UK. 9Centre for 19 
Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, 20 
UK. 21 
 22 
 23 
*Correspondence to: 24 
d.hodson@imperial.ac.uk 25 
d.hodson@bham.ac.uk  26 
g.rutter@imperial.ac.uk 27 
 28 
 29 
Word count (excluding eTOC, highlights, summary, acknowledgements and contributions): 30 
57,796 31 
 32 
Key words: islets, insulin, beta cells, diabetes, optogenetics, imaging 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
  49 
2 
 
HIGHLIGHTS 1 
 Optogenetic and photopharmacological targeting reveals a pacemaker-like beta cell 2 
subpopulation 3 
 These cells, termed hubs, are required for normal insulin release 4 
 Photopainting demonstrates that hubs are highly metabolic and transcriptionally immature 5 
 Hubs are targeted by a diabetic milieu to induce islet failure 6 
 7 
eTOC Blurb 8 
Using advanced imaging approaches, Johnston et al show that a few (1-10%) beta cells exert 9 
disproportionate control over islet responses to glucose. These specialized cells, termed hubs, are 10 
partly immature and highly metabolic. Their failure during type 2 diabetes mellitus may lead to 11 
reduced insulin secretion and impaired glucose homeostasis.  12 
 13 
SUMMARY 14 
The arrangement of beta cells within islets of Langerhans is critical for insulin release through the 15 
generation of rhythmic activity. A privileged role for individual beta cells in orchestrating these 16 
responses has long-been suspected, but not directly demonstrated. We show here that the beta cell 17 
population in situ is operationally heterogeneous. Mapping of islet functional architecture 18 
revealed the presence of hub cells with pacemaker properties, which remain stable over recording 19 
periods of 2-3 hours. Using a dual optogenetic/photopharmacological strategy, silencing of hubs 20 
abolished coordinated islet responses to glucose, whereas specific stimulation restored 21 
communication patterns. Hubs were metabolically-adapted and targeted by both pro-22 
inflammatory and glucolipotoxic insults to induce widespread beta cell dysfunction. Thus, the 23 
islet is wired by hubs, whose failure may contribute to type 2 diabetes mellitus. 24 
  25 
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INTRODUCTION 1 
The release of insulin from pancreatic beta cells is necessary for proper glucose homeostasis in 2 
mammals. Beta cells respond to glucose with increased oxidative metabolism, elevations in 3 
cytosolic ATP/ADP ratio and closure of ATP-sensitive K+ (KATP) channels (Rutter et al., 2015). 4 
The consequent plasma membrane depolarization activates voltage-dependent Ca2+ channels 5 
(VDCC), leading to Ca2+ influx and exocytosis of secretory granules (Rutter et al., 2015). 6 
 The three-dimensional organization of beta cells is also important for the normal 7 
regulation of insulin secretion. Thus, beta cells throughout the islet microorgan display rhythmic 8 
activity patterns in the presence of high glucose (Benninger et al., 2008; Santos et al., 1991). A 9 
role for specialized beta cells in orchestrating these dynamics has long been postulated, including 10 
the presence of putative ‘pacemakers’ (Ämmälä et al., 1991; Benninger et al., 2014; Squires et al., 11 
2002). Indeed, isolated beta cells possess discrete metabolic characteristics and secretory profiles 12 
(Katsuta et al., 2012; Kiekens et al., 1992; Salomon and Meda, 1986), and phase lags in the onset 13 
of electrical activity can be detected between distant islet regions (Benninger et al., 2008; Meda et 14 
al., 1984; Palti et al., 1996). More recent studies have revealed functional differences between 15 
hundreds of individual beta cells monitored in situ in the intact islet (Hodson et al., 2013; Li et 16 
al., 2011; Stozer et al., 2013). Such heterogeneity may be relevant for type 2 diabetes 17 
pathogenesis, since specific insults might target single cells or defined islet regions to induce 18 
insulin secretory failure. However, whether particular subsets of cells drive the behavior of others 19 
has so far been difficult to prove empirically. 20 
 Over the past decade, optogenetics has allowed reversible control of neuronal activity 21 
with light (Zhang et al., 2007). In parallel, photopharmacology has harnessed the power of 22 
azobenzene photoresponsive units to produce exogenously-applied compounds that turn ion 23 
channels and G-protein-coupled receptors into endogenous photoswitches (Broichhagen et al., 24 
2015). As both these approaches are applicable to electrically-excitable endocrine tissue 25 
(Broichhagen et al., 2014; Reinbothe et al., 2014), they afford the unique opportunity to precisely 26 
manipulate cell activity with high spatiotemporal fidelity. Using all-optical interrogation of 27 
individual beta cells in situ, we therefore set out to probe the topology that regulates population 28 
glucose responsiveness, with the aim of identifying the islet-resident pacemaker.  29 
 30 
  31 
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RESULTS 1 
Hubs are a feature of beta cell population dynamics 2 
To visualize the large-scale organization of beta cell activity underlying calcium (Ca2+)-3 
dependent exocytosis of insulin granules, intact mouse islets were subjected to high-speed (2-8 4 
Hz) multicellular Ca2+-imaging (Hodson et al., 2012). This was combined with Monte Carlo-5 
based correlation analyses in which repeated shuffling of Ca2+-events (> 9999 iterations) is used 6 
to determine whether cells are coordinated due to chance or not (i.e. contributing to the same 7 
insulin release event). Together, these approaches allow online mapping of the islet functional 8 
circuitry. Initial experiments confirmed that beta cells form a scale-free network (Stozer et al., 9 
2013) that supports the synchronous propagation of glucose (11 mM)-stimulated Ca2+ waves by 10 
efficiently connecting distant islet regions (R² = 0.72; Fig. 1A). Scale-free networks are 11 
ubiquitous throughout biology, are identified by their power-law link-probability distribution 12 
(Hodson et al., 2010), and adopt a hub and spoke formation where a few cells possess the 13 
majority of connections. Accordingly, a stereotypical feature of such topology in islets was the 14 
non-random appearance of rare super-connected hubs, whose firing activity tended to repetitively 15 
precede and outlast that of the remainder of the population (i.e. was pacemaker-like) (Fig. 1B and 16 
C) (Movie S1).  17 
Such islet architecture was dependent on information exchanges through gap junctions, 18 
since reversible blockade of connexin channels using 18α-glycyrrhetinic acid (AGA) (Farnsworth 19 
et al., 2014) reduced the number of hubs, decreased coordinated population activity, and 20 
increased signal propagation path length (Fig. 1D-G). This may reflect the inability to identify 21 
hubs due to loss of cell-cell entrainment, as well as re-routing of information over longer 22 
distances by the remaining hubs. Notably, no differences in the amplitude of Ca2+ rises were seen 23 
in control and AGA-treated tissue (Fig. S1A-C), suggesting minimal impact upon VDCC activity. 24 
In all cases, parallel experiments were performed using glycyrrhizic acid (BGA), the inactive 25 
precursor of AGA that exerts similar non-specific effects (Desarmenien et al., 2013). Results 26 
could be replicated using mebeverine (Farnsworth et al., 2014) (Fig. S1D), a gap junction 27 
inhibitor with no reported effects on VDCC or KATP channel activity, as well as Gjd2 shRNA to 28 
specifically silence connexin 36 at the islet surface (Fig. S1E-H).  29 
 30 
Hubs are stable and present across species 31 
To assess network topology stability, islets were recorded and then left on the microscope for 32 
between 30 mins and 3 hrs before re-recording. Network topology was stable both over time and 33 
in response to perturbation, as statistically assessed versus a third experiment subjected to either 34 
randomization (i.e. to re-distribute the wiring pattern) or enforced-dissimilarity (i.e. to form a 35 
different wiring pattern) (Fig. 1H and I). Network indices were unaffected in the presence of 36 
either a specific glucagon receptor antagonist (Fig. S1I and J) or a glucagon-neutralizing antibody 37 
(Fig. S1K and L), suggesting that any glucagon present in vitro is unlikely to influence hub 38 
function. Hinting at a conserved role for hub architecture, islet functional topologies were similar 39 
in glucose-stimulated mouse and human islets, as shown by the similar link-probability 40 
distributions (i.e. both are fitted with a power-law of near-identical exponent value). However, 41 
synchrony tended to be compartmentalized into subregions/clusters in human islets (Fig. 1J), in 42 
line with the different structural arrangement of beta- versus alpha-cells in this species (Bosco et 43 
al., 2010). Beta cell Ca2+ responses were not dependent on orientation toward the islet center or 44 
periphery (ΔY Fluo2 = 0.14 ± 0.01 versus 0.13 ± 0.004 AU, periphery versus center, 45 
respectively), and identical results were obtained using the genetically-encoded indicator 46 
GCaMP6 (Fig. 1K and L), engineered to interfere less with intracellular Ca2+ levels.  47 
 48 
A strategy for all-optical interrogation of beta cell function 49 
To functionally dissect the role of hubs, an optogenetic strategy was developed and validated, 50 
enabling electrical silencing following Ins1Cre-directed expression of the light-gated chloride 51 
(Cl-) pump halorhodopsin (eNpHR3.0) (Zhang et al., 2007) in beta cells (Fig. 2A and B). This 52 
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approach allowed the reversible silencing of single beta cell or population Ca2+-spiking activity 1 
and extracellular Ca2+ influx following illumination (λ = 560-590 nm) (Fig. 2C-G) (Movies S2-2 
4). Application of the depolarizing agent potassium chloride was able to overcome silencing by 3 
restoring VDCC activity (Fig. 2H). Of note, wild-type beta cells were refractory to silencing (Fig. 4 
2I and J), and eNPHR3.0-expressing beta cells under irradiation were not further hyperpolarized 5 
using diazoxide to force open KATP channels (Fig. 2K). As measured using patch-clamp 6 
electrophysiology, illumination induced photocurrents (Fig. 3A), leading to membrane 7 
hyperpolarization and electrical silencing only in eNPHR3.0-expressing beta cells (Fig. 3B-D). 8 
Thus, specific and powerful optogenetic silencing could be achieved.  9 
Animals harboring a single eNpHR3.0 allele unexpectedly demonstrated improved 10 
glucose tolerance compared to wild-type littermates, despite normal insulin sensitivity (Fig. 4A-11 
F) and body weight (Fig. 4G and H). This was probably due to enhanced in vivo insulin secretion 12 
(Fig. 4I), as beta cell mass was apparently normal (Fig. 4J). Activation of eNpHR3.0 on an 13 
Ins1Cre background also led to similar results, suggesting that alternation in insulin gene dosage 14 
in the context of the transgene was unlikely to be a contributing mechanism (Fig. 4K and L). 15 
Pertinent to the in vitro studies here, however, isolated islets responded normally to glucose in 16 
terms of ionic fluxes and insulin release (Fig. S2A-I), and eNpHR3.0 does not possess basal 17 
activity in the absence of light (Zhang et al., 2007) (also shown in Fig. 3C). 18 
 19 
Hubs orchestrate beta cell population responses to glucose 20 
By performing analysis in real-time using islets maintained on the microscope stage, hubs could 21 
be identified and subsequently manipulated (Fig. 5A-C). Silencing of individual hubs using a 22 
pinpointing laser had catastrophic consequences for coordinated islet responses to high glucose 23 
(Fig. 5D and E) (Movies S5-6), an effect reversed simply by ceasing illumination (Fig. 5F and 24 
G). The strength of inhibition following targeting of individual hubs tended to be inversely 25 
associated with the number of these cells per islet before silencing (Fig. S2J), suggesting that 26 
some redundancy is present in the system, most likely due to follower cells being controlled by 27 
more than one hub. By contrast, silencing of individual non-hub or follower cells did not 28 
significantly perturb islet dynamics (Fig. 5H), demonstrating the specificity of the approach.  29 
Using a similar technique, hubs were firstly identified at high glucose, before inactivation 30 
using low glucose and stimulation with JB253, an exogenously-applied KATP channel photoswitch 31 
based on glimepiride (Broichhagen et al., 2014). Following targeted illumination of JB253-32 
treated islets, hub connectivity could be mimicked without activation of intervening cells, as 33 
determined by the presence of glucose- and gap junction-dependent entrainment patterns in 34 
follower cells (conduction velocity = 47.0 ± 8.9 µm/s) (Fig. 5I-K). Such effects were unlikely to 35 
stem from diffusion of active JB253, since this molecule turns off within milliseconds in the dark 36 
(Broichhagen et al., 2014), and proximate cells remained unaffected by hub stimulation (Fig. S3).  37 
 38 
Hubs are required for insulin secretion 39 
We were unable to measure insulin secretion accurately from a single islet over the 5 min 40 
experimental period used here, since levels were below the detection sensitivity of current assays. 41 
Therefore, to link hub activity with hormone release, the cell-surface-attached fluorescent Zn2+ 42 
probe JP-107 (Pancholi et al., 2014) was instead employed as a surrogate to dynamically report 43 
Zn2+ co-released with insulin from cells at the islet surface, as previously reported with ZIMIR 44 
(Li et al., 2011). Using this approach, silencing of follower cells or wild-type islets was without 45 
effect, as evidenced by a linear increase in fluorescence due to Zn2+ accumulation at the probe. 46 
By contrast, hub shutdown or global illumination lowered insulin/Zn2+ release to below the 47 
dissolution rate of the probe (i.e. Zn2+ binding is lower than Zn2+ removal) (Fig. 5L).  48 
While it was not technically possible to directly link hub activity with pulsatile insulin 49 
release, the acetocholinomimetic carbachol (Zhang et al., 2008a) was able to accelerate beta cell 50 
population activity (Fig. S3E), without altering the proportion of links or hubs (Fig. S3F, G). 51 
Moreover, rapid imaging performed over dozens of minutes- i.e. within the range of insulin 52 
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pulses (Head et al., 2012)- revealed that hubs are also a feature of population behavior over 1 
longer periods (proportion hubs = 7.1 ± 1.3%; proportion links = 9.7 ± 2.0%). Since carbachol 2 
has been shown to phase-set activity between islets in vitro (Zhang et al., 2008a), 3 
parasympathetic neurons may plausibly target hubs in vivo to synchronize islet activity and 4 
generate insulin pulses.  5 
 6 
Hubs possess a characteristic metabolic signature 7 
We next sought to understand what makes a hub cell unique. Islet-wide Ca2+ signals were 8 
recorded before metabolic profiling of the hub population in the same islet using the 9 
mitochondrial potential dye tetramethylrhodamine ethyl ester (TMRE), which sequesters in 10 
active, hypeporlarized mitochondria. Following stimulation at high glucose, mitochondria in hubs 11 
became more hyperpolarized versus those in non-hubs (Fig. 6A and B), suggesting increased 12 
proton-pumping, ATP synthase activity and ATP generation (Tarasov et al., 2012). While the 13 
duty cycle (i.e. proportion of time the cell spends ‘ON’) was slightly increased in hubs compared 14 
to non-hubs (Fig. 6C), other activity parameters including Ca2+-spiking amplitude and frequency 15 
were broadly similar (Fig. 6D-F). Spatially, hubs and non-hubs were intermingled, with no clear 16 
preference for the islet center or periphery detected for either population based on polar 17 
coordinates (angle and distance taken from the islet center) (Fig. 6G and H).  18 
 19 
Hubs display features of both mature and immature beta cells 20 
Using photoactivatable Tag-RFP (PA-TagRFP) to photopaint single hubs within islets using a 21 
405 nm laser (Fig. S4A and B), post-hoc immunostaining against a variety of markers of beta cell 22 
‘identity’ (Rutter et al., 2015) could be performed (Fig. 6I), without adversely altering Ca2+ 23 
dynamics (Fig. S4C). These studies revealed reduced insulin content, increased glucokinase 24 
(GK/Gck) levels, lowered expression of pancreatic duodenum homeobox-1 (Pdx1), but normal 25 
levels of the mitochondrial import receptor subunit Tom20 in hubs versus the rest of the 26 
population (Fig. 6I and J) (Fig. S5). The transcription factor Nkx6.1, recently shown to be 27 
required for insulin biosynthesis and beta cell proliferation (Taylor et al., 2013), was almost 28 
absent from hubs (Fig. 6I and J). Suggesting that hubs are unlikely to represent a multihormonal 29 
(e.g. Glu+, Ins+) population, no co-localization with glucagon was detected (Fig. 6K). Likewise, 30 
neurogenin-3, a beta cell precursor marker , was undetectable at the protein level in the adult islet, 31 
implying that hubs are unlikely to be trapped in a progenitor state (Fig. 6K). Inspection of 32 
oversampled and deconvolved superresolution confocal images revealed no differences in 33 
mitochondrial distribution/shape or endoplasmic reticulum content in hubs (Fig. 6L-P), although 34 
expression of the sarco(endo)plasmic reticulum Ca2+/ATPase, SERCA2, was markedly reduced 35 
(Fig. 6O and P).  36 
Suggesting a hyposecretory (or degranulated) nature, insulin granule numbers were lower 37 
in hubs versus non-hubs, despite a similar distribution (Fig. 6Q and R). Furthermore, the area of 38 
individual hub cells was comparable to the rest of the population (range = 122-381 µm2 and 194-39 
355 µm2, non-hubs versus hubs, respectively), and their shape appeared to be normal. 40 
Consequently, hubs constitute a metabolically-adapted, repurposed subpopulation of beta cell 41 
which displays features of immature cells.  42 
 43 
Hubs are targeted by diabetic milieu 44 
Lastly, the robustness of hubs was determined by challenging islets with cytokine cocktails (IL-45 
1β/IL-6, or IL-1β/TNF-α) to re-create the pro-inflammatory milieu thought to be associated with 46 
diabetes (O'Neill et al., 2013). Acutely, the application of cytokines led to a large ramp-up in Ca2+ 47 
spiking activity in the presence of high glucose (Fig. S6). However, after only 2 h incubation, a 48 
collapse in hub cell number was apparent (Fig. 7A and B), and this could be viewed in real-time 49 
by recording the same islet left in situ before and during exposure to cytokine (IL-1β/IL-6) (Fig. 50 
7C and D). The cytokine-induced disruption to hub cell function was further evidenced by a 51 
reduction in the number of cells occupying the upper or ‘high connectivity’ region of the link-52 
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probability distribution (Fig. 7E and F), as shown by a decrease in the exponent value of the 1 
power-law fit. This resulted in a dramatic decline in correlated beta cell population function (Fig. 2 
7G) due to the presence of fewer and less well-connected hubs. The actions of cytokines were not 3 
explained by effects on cell viability, as assessed using indices of necrosis (Fig. 7H and I) and 4 
apoptosis (Fig. 7J). However, 2 h cytokine exposure decreased mRNA levels of the major islet 5 
gap junction isoform connexin 36 (GJD2) three-fold (Fig. 7K and L), and this was already 6 
associated with a substantial reduction in gap junction plaque number (Fig. 7M), in line with that 7 
recently reported using a similar paradigm (Farnsworth et al., 2015). Likewise, preferential hub 8 
failure was detected in both rodent and human tissue in response to gluco(lipo)toxic insults (Fig. 9 
7N and O).   10 
8 
 
DISCUSSION 1 
Beta cells are a phenotypically diverse population, presenting a mosaic of metabolic and 2 
electrical activity patterns (Pralong et al., 1990), which is mirrored at the level of insulin 3 
secretory capacity (Katsuta et al., 2012; Kiekens et al., 1992; Li et al., 2011; Salomon and Meda, 4 
1986). When viewed as a population, beta cells are often termed a functional syncytium, although 5 
a role for cell heterogeneity in generating multicellular dynamics has been invoked repeatedly 6 
(Benninger and Piston, 2014; Stozer et al., 2013). Indeed, it has been shown that a subset (~10-15 7 
%) of beta cells may exert a disproportionate influence over islet dynamics (Hraha et al., 2014). 8 
By combining large-scale functional cell mapping with optogenetics and photopharmacology, we 9 
provide here a revised blueprint for islet function whereby a few pioneer hubs with reduced beta 10 
cell identity dictate emergent population behavior in response to glucose. Importantly, hub 11 
topologies are a feature of dynamical systems, including cell networks in the brain and pituitary 12 
(Bonifazi et al., 2009; Hodson et al., 2012), since they are functionally robust at a low wiring cost 13 
(Bullmore and Sporns, 2009) (i.e. the chances of randomly hitting a hub are low). However, 14 
should a hub be specifically targeted, the effects on cell population function are far-reaching, as 15 
observed in the islet during exposure to cytokine or glucolipotoxicity.   16 
 The present study used a single photon-based confocal system to control the activity of 17 
individual hubs or followers within isolated islets. While two photon approaches in theory 18 
increase the accuracy of cell targeting by restricting the beam to within a few microns of the focal 19 
point, there are drawbacks when used with optogenetics. Firstly, a diffraction-limited two-photon 20 
spot (i.e. ~ 500 nm) is insufficient to reliably activate optogenes, and the long excited state 21 
halftime can quickly saturate the rhodopsin (Rickgauer and Tank, 2009). Secondly, commercial 22 
lasers are unable to deliver the > 1100 nm excitation required for eNpHR3.0 activation without an 23 
optical-parametric oscillator (Andresen et al., 2009). By contrast, a single-photon diffraction-24 
limited laser spot (~ 500 nm) of known absorbance cross-spectrum can be introduced to the 25 
surface of the sample, with minimal aberration and steep power drop-off as a function of 26 
1/distance2. Demonstrating the high degree of localization of the effective beam, we were clearly 27 
able to photopaint single cells within an islet, and did not see any population silencing when a 28 
follower cell was targeted.  29 
Using patch clamp recordings of dissociated beta cells, eNpHR3.0 activation 30 
hyperpolarized membrane potential by -60 mV, in line with previous reports (Mattis et al., 2012). 31 
While photocurrent size may be underestimated due to the presence of an electrochemical 32 
gradient, it should be noted that halorhodopsin derives energy from photons rather than the ion 33 
gradient itself (Pfisterer et al., 2009), and the photocycle is unaffected even in the presence of 34 
high Cl-concentration (Varo et al., 1995). In any case, it is unlikely that hyperpolarizing spread 35 
throughout the islet per se could account for these observations, since: 1) only 30% of voltage 36 
spreads to an immediately coupled cell and an 86 mV depolarizing step is required for activation 37 
via gap junctions (Zhang et al., 2008b); and 2) stimulation of follower cells was without effect. 38 
We prefer an explanation whereby large changes in conductance attributable to the hub cell or its 39 
very close neighbors are removed through eNpHR3.0-mediated silencing, leading to impaired 40 
propagation of Ca2+ waves (Benninger and Piston, 2014; Benninger et al., 2008; Zhang et al., 41 
2008b). Although membrane potential was slightly more depolarized following cessation of 42 
illumination, this is also seen in neurons (Mattis et al., 2012) and may reflect the reversal 43 
potential of Cl-. We did not notice significant effects on hub indices during the Ca2+ imaging 44 
studies here due to use of a 5-10 min ‘rest’ period to allow Cl- re-equilibration. 45 
Experiments in which hub cells were stimulated revealed that hubs and followers are 46 
unlikely to form local syncytia. While the exact mechanisms for antipodal signal propagation are 47 
difficult to determine precisely, a role for 3D chains of electrically-coupled cells is plausible, 48 
given that entrainment was markedly blunted by both gap junction blockade and perfusion with 1 49 
mM glucose. Other communication possibilities include autonomic neurons, which possess > 100 50 
µm axonal arborizations in pancreatic slices (Rodriguez-Diaz et al., 2012), and cilia, which 51 
provide a restricted signaling corridor due to their presence in only ~ 25 % of beta cells (Gerdes 52 
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et al., 2014). Along these lines, the effect of hub silencing on islet function was surprisingly 1 
strong, given the relatively mild phenotype of animals deleted for the gap junction protein Cx36 2 
(Ravier et al., 2005). However, considerable redundancy exists in the latter model with Cx30.2 3 
and ephrins providing alternative signaling routes (Farnsworth and Benninger, 2014; 4 
Konstantinova et al., 2007). 5 
An intriguing possibility is that hubs are related to the previously described Pdx1+, 6 
Ins(low) beta cell subpopulation (Szabat et al., 2009), albeit distinct in their low levels of both 7 
markers. Impaired identity, while conceivably restraining stimulus-induced secretion, may also 8 
limit GK-induced proliferation (Porat et al., 2011; Stolovich-Rain et al., 2015) to maintain the 9 
role of these cells as specialized pacemakers. Indeed, high levels of GK expression may sensitize 10 
hubs cells to increases in glucose concentration, allowing these cells to respond earlier and more 11 
robustly than their neighbours. By contrast, the failure of hubs when faced with a 12 
gluco(lipo)toxic/pro-inflammatory milieu indicates that these cells are metabolically fragile. This 13 
vulnerability might reflect high Gck (Roma et al., 2015) expression coupled to low Pdx1 and 14 
SERCA2 levels (Fonseca et al., 2011; Fujimoto et al., 2009), which ultimately lead to ER stress 15 
and cell dysfunction.  16 
We acknowledge that the hub protein characterization performed here constitutes a biased 17 
screen, but it nonetheless provides a strong foundation for understanding the biology of these 18 
unusual cells. In the future, unbiased multiplex approaches, including massive parallel 19 
sequencing (RNASeq) and CyTOF (single cell mass cytometry) (Proserpio and Lonnberg, 2015), 20 
will help define the hub signature. Although attempts were made to obtain dissociated 21 
cells/cytoplasm for these purposes, PA-TagRFP fluorescence disappeared following dissociation 22 
of islets, possibly reflecting either the fragility of these cells, or the fluorophore itself. Similar 23 
problems were encountered with electron microscopy, where available antibodies cannot 24 
differentiate between activated and non-activated PA-TagRFP.  25 
The recording approaches used to monitor hubs were technically-constrained to 2-3 h. 26 
Indeed, such experiments necessitate leaving the islets in situ on the microscope and re-loading 27 
with Ca2+ indicator, since the same field of view must be maintained for analysis purposes. Thus, 28 
it cannot be excluded that hubs may represent a transitory subpopulation that drifts over dozens of 29 
hours in line with transcriptional/translational processes. Indeed, modelling studies predict that 30 
‘pacemakers’ arise from the most excitable beta cell, which is assumed to shift due to a random 31 
distribution of excitability as KATP channel expression levels vary (Benninger et al., 2014). 32 
However, the possibility that such cells may arise during development could not be excluded 33 
(Benninger et al., 2014), and studies in FACS-purified GFP-labelled beta cells suggest the 34 
presence of distinct transcriptional pools, with the proportions remaining similar between animals 35 
and days (Katsuta, Aguayo-Mazzucato et al. 2012). Moreover, to the best of our knowledge, there 36 
is no evidence that KATP channel levels change over time, though the presence of a substantial 37 
proportion of channel subunits on internal membranes (Varadi et al., 2006) may complicate such 38 
measures.  39 
Lastly, it should be noted that experiments in isolated islets may not necessarily reflect 40 
the situation in vivo, where blood flow direction (beta cell -> alpha cell) (Nyman et al., 2008) and 41 
molecule access dynamics (Michau et al., 2015) may all affect the role of hubs in dictating 42 
population dynamics and insulin secretion. This possibility might be tested in the future using in 43 
vivo imaging approaches (Nyman et al., 2008; Speier et al., 2008).  44 
In summary, the present findings provide new insights into the regulation of islet function 45 
by individual beta cells, and the mechanisms that likely target and impair this during type 2 46 
diabetes pathogenesis and treatment. More generally, the paradigm developed here to study the 47 
roles of individual cells within the functioning islet may be broadly applicable to other tissues or 48 
organisms.  49 
  50 
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MATERIALS AND METHODS 1 
Animals, glucose/insulin tolerance testing and insulin measures 2 
Beta cell-specific expression of halorhodopsin, a light-activated hyperpolarising Cl- pump (Zhang 3 
et al., 2007), was achieved by crossing the Ins1Cre deletor strain (Thorens et al., 2014) with 4 
animals engineered to express eNpHR3.0-EYFP following excision of a loxP-flanked STOP 5 
cassette (B6;129S-Gt(ROSA)26Sortm39(CAG-hop/EYFP)Hze/J). For detailed information see 6 
Supplemental Experimental Procedures. 7 
Islet isolation  8 
Animals were euthanized in a rising concentration of CO2 before laparotomy and injection of 9 
collagenase solution (1mg/ml) into the bile duct (clamped at the duodenal ampulla). Following 10 
incubation for 10 min at 37 ⁰C, digested pancreata were subjected to density gradient purification. 11 
Islets retrieved from the interface between the 1.083 g/ml and 1.077 g/ml layers were cultured for 12 
24-72 h in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% foetal calf 13 
serum, 100 U/mL penicillin and 100 µg/mL streptomycin. 14 
Human islet culture 15 
Material from heart-beating donors was obtained from isolation centres in Italy (Pisa and Milan) 16 
and Switzerland (Geneva), with necessary local and national ethical permissions, including 17 
consent from the next of kin. Islets were cultured in RPMI supplemented with 10% foetal calf 18 
serum, 100 U/mL penicillin, 100 µg/mL streptomycin, 0.25 mg/mL fungizone, and supplemented 19 
with 5.5 mM D-glucose. All studies involving human tissue were approved by the National 20 
Research Ethics Committee London (Fulham), REC #07/H0711/114. 21 
Calcium and mitochondrial potential imaging 22 
Multicellular Ca2+ and mitochondrial potential imaging was performed as detailed (Hodson et al., 23 
2013). Single cell silencing in eNpHR3.0-expressing tissue was achieved using a λ = 585 nm 24 
laser (300 mW) linked via a single-mode fibre optic to a custom-manufactured dichroic array, 25 
configured to deliver a diffraction-limited (~ 500 nm) spot (6.8-23.4 mW/mm2) to the focal plane 26 
(Cairn Research). Single cell stimulation was performed using the photoswitchable sulfonylurea 27 
JB253 and a diffraction-limited λ = 470 nm laser. Mitochondrial potential was monitored using 28 
TMRE. For detailed information see Supplemental Experimental Procedures. 29 
 30 
 31 
Electrophysiology 32 
Pancreatic islets were dissociated into single β-cells and plated onto glass coverslips. 33 
Electrophysiological recordings were performed in either perforated patch-clamp or whole-cell 34 
configuration using an EPC9 patch-clamp amplifier controlled by Pulse acquisition software 35 
(HEKA). For detailed information see Supplemental Experimental Procedures. 36 
Dynamic insulin secretion measures  37 
Zinc (Zn2+) co-released from insulin-containing granules was measured as a proxy for insulin 38 
secretion using the chemical probe JP-107 (300 µM), as described (Pancholi et al., 2014). For 39 
detailed information see Supplemental Experimental Procedures. 40 
 41 
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 1 
Generation of adenoviral PA-TagRFP and photopainting 2 
cDNA encoding the photoactivatable fluorescent protein PA-TagRFP (Subach et al., 2010) was 3 
cloned into pShuttleCMV via Xho 1 and Xba I sites before recombination with pAdEasy1 and 4 
virus production as described (Luo et al., 2007). Islets were incubated for 48 h with adenovirus 5 
harboring PA-TagRFP at a multiplicity of infection (MOI) = 100. Photopainting was performed 6 
post facto following fMCI and correlation analysis by bounding the identified cell(s) with a 7 
region of interest (ROI) and scanning the area with a λ = 405 nm diode laser (x20/0.8NA 8 
objective).  9 
shRNA-silencing of connexin 36 10 
For detailed information see Supplemental Experimental Procedures. 11 
Immunohistochemistry 12 
Islets were fixed at 4 ⁰C overnight in paraformaldehyde (4%, wt/vol) before permeabilization 13 
(PBS + Triton 0.1%) and application of either guinea pig anti-insulin 1:200 (DAKO), mouse anti-14 
glucagon 1:1000 (Sigma), rabbit anti-glucokinase 1:50 (Santa-Cruz), rabbit anti-Pdx1 1:50 15 
(Rafiq, 2000), goat anti-Pdx1 1:2500 (Abcam), mouse anti-neurogenin-3 (Ngn3) 1:1000 (DSHB 16 
Hybridoma Product F25A1B3), rabbit anti-Tom20 1:250 (Santa Cruz Biotechnology), rabbit anti-17 
Nkx6.1 1:250 (Sigma), rabbit anti-SERCA2 1:250 (Alomone Labs) or rabbit anti-PDI 1:200 (Cell 18 
Signaling Technology) antibodies for 24-48 h at 4⁰C. Staining was revealed following 2 h 19 
incubation at room temperature with secondary antibodies conjugated to Alexa Fluor-488, -568 20 
and -633 (1:500) (Invitrogen). Connexin 36 (Cx36) staining was performed as above, but 21 
following 10 min fixation in ice-cold acetone and using rabbit anti-Cx36 1:50 (Zymed). To live 22 
image mitochondria, islets were incubated in 100 nM MitoTracker Red FM (Invitrogen) for 30 23 
min.  24 
Beta and alpha cell mass  25 
For detailed information see Supplemental Experimental Procedures. 26 
Necrosis and apoptosis assays 27 
For detailed information see Supplemental Experimental Procedures. 28 
Real-time PCR 29 
Relative mRNA abundance was determined on an Applied Biosystems ABI 7500 Fast Real-Time 30 
PCR System using SYBR Green reagents and primers against connexin 36 (Gjd2) 31 
(GATTGGGAGGATCCTGTTGAC and AGGGCTAGGAAGACAGTAGAG). Gene expression 32 
was normalised to β-actin (CGAGTCGCGTCCACCC and CATCCATGGCGAACTGGTG) and 33 
fold-change in mRNA expression compared to control calculated using the 2−ΔΔCT.  34 
Correlation, similarity analyses and polar coordinates 35 
Individual EYFP-expressing beta cells were identified using an ROI to produce a mask overlay of 36 
the imaged population. Correlation analyses were then performed in MATLAB on Hilbert-Huang 37 
transformed Ca2+ signals using binarization and matrix analyses, and statistical significance 38 
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assigned using non-deterministic (Monte-Carlo methods), as described (Hodson et al., 2010; 1 
Hodson et al., 2012). For detailed information see Supplemental Experimental Procedures. 2 
Measurements of insulin secretion from isolated islets 3 
Insulin secretion was measured using static incubation of islets (batches of 6-8) for 30 min in 4 
HEPES-bicarbonate buffer at 37°C containing the indicated glucose concentrations (da Silva 5 
Xavier et al., 2009). Insulin concentration in the supernatant was determined using a proprietary 6 
Homogeneous Time Resolved Fluorescence (HTRF)-based assay (Cisbio) according to the 7 
manufacturer’s instructions. 8 
Cytokines and glucolipotoxicity 9 
Interleukin 1 beta (IL-1β), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) (all from 10 
R&D Biosystems) were stored as stock solutions at -20 ⁰C and used at 20 pg/ml, 40 pg/ml and 20 11 
pg/ml, respectively (Maedler et al., 2004; O'Neill et al., 2013). For gluco(lipo)toxicity studies, 12 
cells were exposed to 33mM glucose and/or 0.5 mM BSA-conjugated palmitate for 48 h. 13 
Statistical analyses 14 
Data normality was assessed using the D’Agostino Pearson omnibus test. Pairwise comparisons 15 
were performed using paired or unpaired Student’s t-test. Interactions between multiple 16 
treatments were determined using one-way or two-way ANOVA (adjusted for repeated measures 17 
as necessary), followed by pairwise comparisons with Bonferonni’s or Tukey’s posthoc tests. 18 
Analyses were conducted using R (R-project), Graphpad Prism 6.0 (Graphpad Software), IgorPro 19 
(Wavemetrics) and MATLAB (Mathworks), and results deemed significant at P<0.05. Unless 20 
otherwise stated, data are presented as the mean ± SEM. 21 
  22 
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 1 
Fig. 1. Functional mapping of beta cell population dynamics (A) At elevated glucose (11 mM), islets 2 
house a scale-free network where a few (< 10 %) beta cells host the majority of correlated links (P<0.01), 3 
as shown by the power law-fitted probability distribution (LC, low connectivity range; HC, high 4 
connectivity range) (R² = 0.72) (n = 12 recordings from 5 animals). To better demonstrate the distribution, 5 
a log-log scale is used to convert the power-law into a linear relationship. (B) Representative functional 6 
connectivity map displaying the x-y position of analyzed cells and their links (followers, blue; hubs, red) 7 
(scale bar = 20 µm). (C) Representative trace showing that hub (red) activity tends to precede and outlast 8 
that of follower cells (mean lag value calculated from n = 5 recordings from 3 animals). (D) Treatment of 9 
islets with the gap junction blocker 18α-glycyrrhetinic acid (AGA; 20 µM) (left), but not its inactive 10 
analog glycyrrhizic acid (BGA; 20 µM) (right) reduces the proportion of hubs (n = 9 recordings from 5 11 
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animals) (before, islet in control buffer; after, same islet in the presence of either AGA or BGA). (E) As 1 
for (D) but the percentage (%) of correlated links. (F and G) Gap junction blockade increases the length 2 
between correlated links (n = 9 recordings from 5 animals). (H) Wiring patterns are statistically stable 3 
upon re-recording after 30 min, as determined against the same islet but with enforced dissimilarity (n = 8 4 
recordings from 5 animals). (I) Wiring patterns are statistically stable upon re-recording after 30 min 5 
(Fluo2) and 3 hrs (GCaMP6), as compared to the randomly-shuffled matrix for each islet (n = 4-6 6 
recordings from 2-3 animals). (J) As for (A) but showing almost identical link-probability distributions in 7 
mouse and human islets, as shown by the exponent values (κ) for the fitted power laws (n = 8 recordings 8 
from 3 donors). (K-L) Imaging using GCaMP6 and Fluo2 return similar hub and link proportions (n = 12 9 
recordings from 4-6 animals). Data are means ± SEM.*P<0.05 and **P<0.01 and NS, non-significant.  10 
  11 
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 1 
Fig. 2. Reversible and repeated silencing of beta cell Ca
2+
-spiking activity. (A) Immunostaining for 2 
insulin showing membrane-localized expression of eNpHR3.0-EYFP in beta cells (Dapi, nuclei) (n = 3 3 
preparations). (B) As for (A), but immunostaining for glucagon showing absence of eNpHR3.0-EYFP in 4 
alpha cells (n = 3 preparations). Scale bar = 50 µm (or 10 µm for dissociated cells). (C) Reversible 5 
silencing of beta cell Ca
2+
 oscillations in eNpHR3.0-expressing islets in response to illumination with λ = 6 
561 nm (n = 5 recordings). Treatment of islets with nifedipine 50 µM (Nif; black trace) abolishes the 7 
rebound in Ca
2+
 upon inactivation of eNpHR3.0 (n = 5 recordings) (traces are from different islets). (D) As 8 
for (C) but in the presence of verapamil 10 μM (Ver; black trace) (n = 5 recordings) (traces are from 9 
different islets). (E) Perifusion of islets with zero Ca
2+ 
supplemented with EGTA was able to prevent 10 
recovery of [Ca
2+
]i in islets following silencing (n = 5 recordings). (F) Beta cell population Ca
2+
-spiking 11 
activity can be repeatedly silenced following exposure to λ = 561 nm (n = 3 recordings). (G) Global 12 
silencing (λ = 561 nm) induced a decrease in intracellular Ca
2+
 concentrations ([Ca
2+
]i) throughout the 13 
islet, whereas a diffraction-limited laser (λ = 585 nm) only silenced [Ca
2+
]i in the targeted area (n = 3 14 
recordings). (H) Silencing can be overcome using the depolarizing agent KCl 30 mM to re-activate VDCC 15 
(n = 6 recordings). (I-J) Wild-type islets (NpHR
-/-
) do not respond to illumination with decreases in [Ca
2+
]i 16 
(n = 5 recordings). (K) Diazoxide (Dz) 100 µM is unable to further suppress [Ca
2+
]i in eNpHR3.0-silenced 17 
islets (n = 5 recordings). Where indicated, tolbutamide (Tb) 100 µM was added to maintain a stable 18 
plateau from which to better detect silencing. G17, glucose 17 mM; G11, glucose 11 mM.; G3, glucose 3 19 
mM. 20 
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 1 
Fig. 3. Yellow light hyperpolarizes eNpHR3.0-expressing pancreatic beta-cells. (A) Voltage clamp 2 
(whole cell) recording of an eNpHR3.0-expressing beta cell showing induction of photocurrents with 3 
yellow light (λ = 572 nm). (B-D) Representative current clamp (perforated patch) recordings showing 4 
reversible membrane hyperpolarization with yellow light (λ = 572 nm) in an eNpHR3.0-expressing, but 5 
not wild-type (WT) beta cell. In all cases, n = 6-11 cells. Data are means ± SEM. ***P<0.001.  6 
 7 
 8 
 9 
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 12 
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 1 
Fig. 4. Glucose homeostasis in eNpHR3.0 mice. (A-B) Glucose tolerance is improved in male 8 wk 2 
Ins1Cre
+/-
;eNpHR3.0-EYFP
fl/-
(NpHR) animals (n = 7) compared to Ins1Cre
-/-
;eNpHR3.0-EYFP
fl/-
 (wild 3 
type, WT) littermates (n = 7) (i.e. activation of Ins1Cre on an eNpHR3.0-EYFP background), as assessed 4 
using IPGTT. (C) Insulin sensitivity is similar in male NpHR mice animals and WT littermates (n = 6-11), 5 
as determined using ITT. (D-E) As for (A-B) but female 8 wk mice (n = 7-9). (F) As for (C) but female 8 6 
wk (n = 4). (G-H) Fasting body weight and growth curves (non-fasted) are similar in WT and NpHR 7 
animals (n = 9-13). (I) In vivo insulin release tended to be increased in NpHR compared to WT animals at 8 
15 min post-IP glucose injection (n = 4). (J) Beta cell mass, alpha cell mass and alpha:beta cell ratio are 9 
similar in WT and NpHR animals (n = 3). (K-L) As for (A-B) but glucose tolerance in 6 and 8 wk 10 
Ins1Cre
+/-
;eNpHR3.0-EYFP
fl/-
(NpHR) (n = 3-4) compared to Ins1Cre
+/-
;eNpHR3.0-EYFP
-/-
 (wild type, 11 
WT) animals (n = 8) (i.e. activation of eNpHR3.0-EYFP on an Ins1Cre-background). Data are means ± 12 
SEM. **P<0.01 and NS, non-significant. 13 
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 1 
Fig. 5. Real-time analysis and targeting of beta cell hubs. (A-B) Schematic showing the effects of 2 
eNpHR3.0 activation upon beta cell Ca
2+
 signaling (A), and snapshot showing placement of a diffraction-3 
limited laser spot over a discrete islet region (B) (scale bar, 25 µm; image cropped to display a single islet). 4 
(C) Experimental flowchart for real-time manipulation of hub function. (D to F) Representative functional 5 
connectivity map and activity plots at high glucose (11 mM), before (D), during (E) and after (F) 6 
optogenetic silencing (identified hub cell; red). A representative Ca
2+ 
trace is displayed above. (G-H) 7 
Summary data showing a reversible collapse in the proportion of correlated cell links following hub (G), 8 
but not follower (H) silencing (n = 7-9 recordings from 4 animals). (I-K) Representative experiment 9 
showing cell-cell entrainment patterns (I) and representative Ca
2+
 rises in linked cells (J) following 10 
photopharmacological stimulation of an identified hub (red) at 3 mM glucose using JB253 (50 µM) (low 11 
Glu = 1 mM glucose). Box and whiskers plot shows the range and mean number of hub- or follower-12 
entrained cells under normal (high glucose) conditions, and following targeted stimulation using JB253 in 13 
the presence of control (Con; 3 mM glucose), BGA, AGA and low glucose (1 mM) (K) (n = 4-7 recordings 14 
from 3-4 animals). (L) Insulin secretion measured using JP-107 is unaffected following illumination of 15 
follower cells or wild-type (WT) islets, but suppressed in response to hub or islet (global) shutdown (mean 16 
traces shown) (n = 8 islets from 4 animals). Scale bars = 20 µm. Data are means ± SEM. *P<0.05 and NS, 17 
non-significant.  18 
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Fig. 6. Phenotypic profiling of hub cell function. (A-B) Hubs display elevated mitochondrial potential 2 
(Ψm) compared to the rest of the population, as measured using TMRE to label active mitochondria (n = 9 3 
recordings from 3 animals) (G3, glucose 3 mM; G11, glucose 11 mM). (C-F) Duty cycle (i.e. fraction 4 
spent ‘ON’) (C), and Ca
2+
 oscillation amplitude (D) and frequency (E-F) are similar in hubs and followers 5 
(n = 8 recordings from 4 animals). (G-H) Polar coordinates showing that hub distribution is not spatially-6 
biased versus followers (angle θ and distance r from the islet center 0,0 are shown in the bar graphs). (I-J) 7 
PA-TagRFP-identified hubs (red; RFP) express less insulin (Ins), less Pdx1, less Nkx6.1, more glucokinase 8 
(GK), and normal Tom20 compared to the rest of the population (n = 5-9 hubs from 3-4 animals). (K) 9 
Hubs were not immunopositive for glucagon (Glu), and Neurogenin 3 (Ngn3) expression was largely 10 
undetectable in the adult islet. (L-N) High resolution Z-projections of Tom20- and MitoTracker-stained 11 
islets (L) reveal normal mitochondrial sphericity (M) and length (N) (white-dashed line, hub; blue-dashed 12 
line, non-hub) (3D render shown for TOM20 and Z-projection for MitoTracker) (n = 6 hubs from 3 13 
animals). (O-P) As for (L-N), but staining for PDI and SERCA2 showing normal ER abundance and 14 
lowered Ca
2+
-ATPase content in hubs (Z-projection, left; 3D render, right) (n = 4-5 hubs from 3 animals). 15 
(Q-R) High-resolution snapshot of insulin staining (Q) showing a reduction in granule content in hubs 16 
(red) (R) (n = 6 hubs from 3 animals). Scale bars = 12.5 µm. Data are means ± SEM. *P<0.05, **P<0.01 17 
and NS, non-significant. 18 
 19 
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 21 
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 1 
Fig. 7. Disruption of hubs by pro-inflammatory and glucolipotoxic insults. (A-B) IL-1β/IL-6 and IL-2 
1β/TNF-α reduce hub number after 2 h (n = 6 islets from 3 animals). (C-D) Cytokine (Cyto; IL-1β/IL-6) 3 
decreases hub number in real-time (n = 8 from 4 animals). (E-F) Cytokine alters the distribution of 4 
correlated links and power-law scaling exponent (k) value, indicating a decreased number of cells in the 5 
high connectivity (i.e. hub) range (n = 8 from 4 animals) (R² = 0.38–0.74). The power-law was log-log 6 
transformed to a linear relationship to better demonstrate the distribution. (G) Cytokine (IL-1β/IL-6) 7 
exposure dramatically reduces the proportion of correlated links. (H to I) Application of IL-1β/IL-6 or IL-8 
1β/TNF-α for 2 h (H) or 4 h (I) is not cytotoxic (n = 21 islets per condition from 6 animals) (scale bar, 25 9 
µm). (J) 2 h application of IL-1β/IL-6 or IL-1β/TNF-α does not induce apoptosis (n = 18-20 islets from 5 10 
animals). (K-L) IL-1β/IL-6 and IL-1β/TNF-α decrease connexin 36 (GJD2) mRNA levels (n = 10 11 
animals). (M) IL-1β/IL-6 and IL-1β/TNF-α reduce the number of immunostained gap junction (Cx36) 12 
plaques (n = 9-12 islets from 6 animals) (scale bar, 12.5 µm). (N) Glucotoxicity (Glucotox) and 13 
glucolipotoxicity (Glucolipotox) reduce the proportion of hubs and correlated links in mouse islets (n = 6 14 
animals). (O) As for (N) but showing effects of glucolipotoxicity-alone on human islets (n = 5 donors). 15 
Data are means ± SEM. *P<0.05, **P<0.01 and NS, non-significant. 16 
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